S. 1250 · 118th Congress (2023–2025)
Drug-price Transparency for Consumers Act of 2023
Drug-price Transparency for Consumers Act of 2023 or the DTC Act of 2023
This bill requires consumer advertisements for drugs and biologicals to include certain price information if the drug or biological is (1) covered under Medicare or Medicaid, and (2) required to include a risk summary under current law. The requirement does not apply to advertisements for drugs or biologicals with a wholesale cost of less than $35 for a one-month supply.
Each violation of this requirement is subject to a civil penalty of not more than $100,000.
Show official title
A bill to amend title XI of the Social Security Act to require that direct-to-consumer advertisements for drugs and biologicals include an appropriate disclosure of pricing information.
Expired in Senate committee
Derived from the legislative history, not an official disposition.
Latest actionReferred to committee
This bill’s path
This is S. 1250’s recorded path, not a universal congressional workflow.
How bills become lawAll actionsIntroduced
Passed Senate
Passed House
Sent to President
Signed into law
Expired
- Sponsor
- Sen. Richard J. Durbin (D-IL)
- Cosponsors
8 cosponsors
6 original · 2 later
3 R · 4 D · 1 I
- Sen. Tammy Baldwin (D-WI)· Original · Apr 20, 2023
- Sen. Richard Blumenthal (D-CT)· Original · Apr 20, 2023
- Sen. Mike Braun (R-IN)· Original · Apr 20, 2023
- Sen. Chuck Grassley (R-IA)· Original · Apr 20, 2023
- Sen. Angus S. King Jr. (I-ME)· Original · Apr 20, 2023
- Sen. J. D. Vance (R-OH)· Original · Apr 20, 2023
- Sen. Sherrod Brown (D-OH)· Later · Jul 12, 2023
- Sen. Tina Smith (D-MN)· Later · Sep 7, 2023
- Policy area
- Health
- Subjects
- Administrative law and regulatory procedures
- Civil actions and liability
- Department of Health and Human Services
- Health care costs and insurance
- Marketing and advertising
- Prescription drugs
On this page
Timeline
i
In chronological order. Major procedural acts are shown in full. Committee work and ordinary amendments fold in place where they happened, so they do not jump the sequence or stretch the timeline.
Introduced in Senate
Document: Introduced in Senate
Sources
- Congress.gov action
- Library of Congress
- Latest
Referred to committee
Congressional Record S1297; text: CR S1297-1298; S1297; text: CR S1297-1298
Read twice and referred to the Committee on Finance.
Sources
- Congress.gov action
- Senate
Expired
Introduced → Referred to Senate Finance → No further action before the 118th Congress ended.
Committees
Text & titles
i
Each distinct name Congress.gov recorded, once. Official, short, display, and popular titles stay distinct when the wording differs. The same wording is not repeated for every text version.
| Version | Date | Links |
|---|---|---|
| Introduced in Senate |
Titles (2)
Drug-price Transparency for Consumers Act of 2023
Display title, Short title · Introduced in Senate
A bill to amend title XI of the Social Security Act to require that direct-to-consumer advertisements for drugs and biologicals include an appropriate disclosure of pricing information.
Official title · Introduced in Senate